Dementia Pipeline Review published

CHICAGO: This report provides comprehensive information on the therapeutic development for Dementia Associated With Alzheimer’s Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates.

It also reviews key players involved in the therapeutic development for Dementia Associated With Alzheimer’s Disease and special features on late-stage and discontinued projects…

Full story covered in the Dementia Business Weekly.

Leave a Reply

Your email address will not be published. Required fields are marked *


*


*SPAM CHECK Time limit is exhausted. Please reload the CAPTCHA.